NuriBio
PrivateLast Round
M&A
Nov 9, 2022
Est. Valuation
$21.4M
Total Funding Raised
$4.5M
Company Overview
NuriBio operates in Healthcare & Life Sciences and is based in Anyang. Its latest recorded funding round was a VC Round in August 2021.
NuriBio is a biotechnology company that develops proprietary genetic analysis tools and diagnostic kits for research and medical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuriBio Comparables
Compare NuriBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenoSensor Corporation | 81% | |
| OriGene Technologies | 75% | |
| Bioneer Corporation | 71% |
For institutional investors. Book with your work email.
NuriBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 9, 2022 | ||||
| VC Round | Aug 27, 2021 | ||||
| Series A | Jan 1, 2019 | ||||
| VC Round | Aug 9, 2018 | ||||
| Grant | Jun 1, 2018 | ||||
Accelerator | Apr 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NuriBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seoul Business Agency | Series A |
| Dadam Investment | VC Round |
| IBK Capital | Series A |
| Magna Investment | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 82% MoM.
- Nov 9, 2022
$6.08M round led by Celestra Inc.
For institutional investors. Book with your work email.
NuriBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NuriBio's valuation, stock price, and market status.
Is NuriBio a public or private company?
NuriBio is a private company.
What is the current stock price of NuriBio?
NuriBio is a private company, so its shares have no public market price. Caplight tracks NuriBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NuriBio worth (valuation)?
NuriBio's valuation is estimated at $21.4M based on funding round data.
Can I buy NuriBio stock?
NuriBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NuriBio's last funding round?
NuriBio's most recent funding round was M&A on November 9, 2022.
Who are the main investors in NuriBio?
Key investors in NuriBio include Magna Investment.
Will NuriBio IPO soon?
No public IPO plans have been announced for NuriBio.
How can I track NuriBio secondary market activity?
Caplight tracks bids, offers, and trades in NuriBio's shares on secondary markets.